• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL1800067 Risankizumab注射液(ABBV-066)300mg/3.33mL risankizumab Injection Biological Products Import Drug Application 2018-12-14 AbbVie Inc. Abbvie Inc In Review 2018-12-13 view